Jounce Therapeutics inc (JNCE) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access JNCE Annual Balance Sheets →
Quarterly balance sheet trends provide context on Jounce Therapeutics inc's liquidity, leverage, and long-term financial structure.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2022)
(Sep 30 2022) (Jun 30 2022) (Mar 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent150.57
Available-for-sale Securities, Debt Securities, Current MA38.97
Cash & Short-term Investments188.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current7.69
Total Current Assets197.23
Equipment/Property/Plant Net3.72
Long-term investments0.00
Other Assets, Noncurrent4.00
Operating Lease Right Of Use Asset8.60
Total Assets212.55
Liabilities
Accounts Payable, Current AC2.10
Accrued Liabilities, Current AC17.15
Other Liabilities, Current4.33
Total Current Liabilities23.57
Total Long-term Debt0.00
Other liabilities, Noncurrent5.87
OperatingLeaseLiabilityNoncurrent5.87
Operating Lease Liability Current4.15
Total Liabilities29.44
Stockholders' Equity
Common Stock Value0.05
Additional Paid In Capital Common Stock476.53
Retained Earnings / Accumulated Deficit-292.79
Other Equity-0.68
Common Stockholder's Equity183.11
Total Stockholder's Equity183.11
Liabilities & Stockholder's Equity212.55
4 historic quarters locked

Sign in to unlock the full Jounce Therapeutics inc balance sheet history.

About Jounce Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001640455-23-000066

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.